Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Doctors working on the first non-invasive diagnostic test for endometriosis have published the results of the DETECT phase 2 clinical trial, and the news, according to the researchers, is good. Clinical trial results hint that women might soon be able to opt for an endometriosis scan instead of a surgery. This April, Oxford University, UK, based gynaecologists […]

The post Phase 2 clinical trial Shows ‘Exciting’ Results for New Non-invasive Endometriosis Test appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Today, imaging systems are a part of healthcare, and this need demands constant solutions that are both safe and compliant. Radiation protection in X-ray rooms using Lemer Pax is becoming a key benchmark for hospitals and imaging centres seeking a reliable infrastructure for demanding environments. By using new diagnostic and therapeutic technologies, shielding is no […]

The post Radiation protection in modern imaging and theranostics environments appeared first on Medical News Bulletin.

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Most adults associate eye exams with experiencing an uncomfortable urge to buy new glasses, feeling dryness after a prolonged wear of contact lenses, or noticing blurriness when reading print. Although these symptoms are valid reasons for booking an eye exam, they are not the only reasons. An adult eye exam is important in assessing the […]

The post Your Eyes Need Checkups Too, Not Just New Glasses appeared first on Medical News Bulletin.

The FDA approved risankizumab-rzaa for children aged at least 6 years with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy or active psoriatic arthritis, AbbVie announced in a press release.
In addition, the FDA approved a new 55 mg prefilled syringe to support weight-based dosing for patients who weigh less than 40 kg. A 150 mg prefilled syringe and pen are approved for patients who weigh at least 40 kg, according to the release.
With the approval, risankizumab-rzaa (Skyrizi) is “the first and only [interleukin-23] inhibitor approved in the

Merz Therapeutics announced the FDA approved a label update to expand incobotulinumtoxinA’s pediatric upper limb spasticity indication to include children and adolescents aged at least 2 years with cerebral palsy.
IncobotulinumtoxinA (Xeomin) was previously approved by the FDA in 2010 for adults with cervical dystonia after showing improvements in clinical studies for cervical dystonia-related severity, disability and pain, according to a company press release.
“Spasticity associated with cerebral palsy can place a significant burden on children and families, affecting comfort,

Flattened corneal curvatures were not associated with worse visual outcomes after myopic PRK, according to a study published in Journal of Refractive Surgery.
Waseem Nasser, MD, PhD, of Rambam Health Care Campus, Haifa, Israel, and colleagues wrote that it has been assumed that eyes with significantly flattened corneas after PRK experience worse visual outcomes, but the relationship has not been fully explored or defined.
“Others have reported that patients with extremely flat corneas do not necessarily experience worse outcomes,” they wrote. “The uncertainty surrounding this issue highlights

The FDA has approved a prefilled injection device for adults with polycythemia vera, according to a press release.
The ropeginterferon alfa-2b-njft device (BESREMi Pen, PharmaEssentia) allows for self-administration, differentiating it from the currently available prefilled syringe, which previously received FDA approval in 2021. PharmaEssentia expects the pen “to become commercially available in the U.S. in the coming weeks,” according to the release.
“With this new device, we’re empowering more people living with [polycythemia vera] to manage their condition with

Editor’s note: This is a developing news story. Please check back soon for updates.
The FDA cleared Be Free Day toric contact lenses for the correction of myopia and other refractive errors, according to a press release from Euclid Vision.
Be Free Day (toufilcon B) silicone hydrogel toric lenses are set to launch this fall with the following parameters:
The lenses feature a “multistep design” patented by Brien Holden Vision Institute that enables “gradual power transitions,” according to Euclid. While not approved for myopia management, they include a peripheral

A previously healthy 16-month-old was seen with a recent onset of irritability and a bumpy rash.
The father did not observe any other concerning symptoms, such as fever, poor appetite, emesis or diarrhea. He could not pinpoint when the fussiness started, but it had been worsening for about a week. Immunizations were up to date for the child’s age, and he had no other medical concerns.
According to family history, the child had no siblings, and was in a large daycare setting daily while the parents were at work. There had been no known sick contacts at home or among the adults in his daycare

Patients who underwent sutureless scleral fixation of a one-piece IOL had good outcomes at 5 years, according to a study published in Journal of Refractive Surgery.
Agostino S. Vaiano, MD, PhD, of Santa Croce e Carle Hospital, Cuneo, Italy, and colleagues wrote that while previous studies have explored both sutured and sutureless posterior chamber IOLs, data have not revealed a superior option.
“Scleral sutured fixated IOLs present several challenges, including a steep learning curve, the need for large corneal incisions, and the risk of suture degradation or breakage over time,” they wrote.